Tuesday, September 23, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

ThredUp Reports Strong Revenue Growth in Q4 2023 and Optimistic Outlook for 2024

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
DrugRetailers Stock Market Today
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

ThredUp, a leading fashion resale platform, announced its quarterly financial results on March 4, 2024. The company reported a loss of $(0.140) per share, which was below analysts’ expectations by 16.67%. However, ThredUp exceeded revenue projections with quarterly sales reaching $81.393 million, a 1.32% increase from the forecasted $80.329 million. This marks a significant 14.13% growth compared to the same period last year.

In the fourth quarter of 2023, ThredUp generated $81.4 million in revenue, demonstrating a strong 14% year-over-year improvement. Looking ahead, the company is optimistic about its financial performance in 2024, forecasting revenue in the range of $340 million to $350 million. ThredUp also aims to achieve an Adjusted EBITDA margin between 0.5% and 1.5%, indicating a positive outlook for the year ahead.

TDUP Stock Shows Promising Price Momentum on March 4, 2024: Analysis and Insights

On March 4, 2024, TDUP stock showed some promising signs of price momentum. The stock closed at $2.36, which was a significant increase of $0.25 or 11.85% from the previous market close. This positive movement was certainly welcomed by investors who have been closely monitoring the stock’s performance.

However, despite this initial surge, TDUP is still trading in the middle of its 52-week range and below its 200-day simple moving average. This indicates that while there may have been some short-term gains, the stock may still be facing some resistance in reaching higher price levels.

Furthermore, in after-hours trading, TDUP experienced a slight drop of $0.18. While this may be a cause for concern for some investors, it is important to remember that after-hours trading can often be more volatile and may not always reflect the true value of a stock.

Overall, the performance of TDUP on March 4, 2024, showed some positive price momentum with a notable increase in share price. However, investors should continue to monitor the stock closely and consider the broader market trends before making any investment decisions.

TDUP Stock Performance Analysis: Revenue Up, Net Income Down – March 4, 2024

On March 4, 2024, TDUP stock had a mixed performance based on the financial data provided by CNN Money. The company’s total revenue for the past year was $288.38 million, showing a 14.53% increase compared to the previous year. However, in the third quarter, the total revenue dropped to $82.05 million, holding flat since the last quarter.

The net income for TDUP was -$92.28 million for the past year, indicating a 46.07% decrease from the previous year. In the third quarter, the net income improved slightly to -$18.08 million, showing a 3.61% increase since the last quarter.

Earnings per share (EPS) for TDUP were -$0.92 for the past year, reflecting a 44.05% decrease from the previous year. In the third quarter, the EPS improved to -$0.17, representing a 5.37% increase since the last quarter.

Overall, TDUP stock had a challenging year with a significant drop in net income and earnings per share. However, there were signs of improvement in the third quarter, with a slight increase in net income and EPS compared to the previous quarter.

Tags: TDUP
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Doctor on mobile phone

Health Tech Innovations: Transforming Healthcare Delivery and Monitoring

Revenue Operations: How Innovative Technology is Transforming Sales Strategies

Revenue Operations: How Innovative Technology is Transforming Sales Strategies

Automotive Stock Market Today

NIO Inc Announces Strong Vehicle Sales in Fourth Quarter of 2023

Recommended

Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago
Footwear Industry Markets and money (1)

Anne Mehlman Appointed as EVP and President of Crocs Brand Search Underway for New CFO

2 years ago
Moog Stock

Security Breach at Defense Contractor Moog Highlights Sector Vulnerabilities

4 weeks ago

Malibu Boats Remains Optimistic Despite Decline in Earnings

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Can Pacific Biosciences’ New Screening Strategy Reverse Its Fortunes?

Opendoor Shares Face Reality Check as Influencer Support Shifts

Ziff Davis: Insider Confidence Clashes with Cautious Analyst Outlook

Main Capital Shares Face Pressure Despite Dividend Boost

Halozyme’s Patent Battle with Merck: A Potential Billion-Dollar Inflection Point

Seacoast Banking of Florida: A Regional Powerhouse Gaining Momentum

Trending

Unitedhealth Stock
Analysis

UnitedHealth Navigates Mounting Cost Pressures After Volatile Year

by Robert Sasse
September 23, 2025
0

UnitedHealth Group is working to regain its footing following a challenging period. The managed care giant's stock,...

BigBear.ai Stock

BigBear.ai Stock: Low Valuation Masks Deeper Fundamental Concerns

September 23, 2025
Coherus BioSciences Stock

Coherus BioSciences: A High-Stakes Pivot to Oncology

September 23, 2025
Pacific Biosciences Stock

Can Pacific Biosciences’ New Screening Strategy Reverse Its Fortunes?

September 23, 2025
Opendoor Stock

Opendoor Shares Face Reality Check as Influencer Support Shifts

September 23, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • UnitedHealth Navigates Mounting Cost Pressures After Volatile Year
  • BigBear.ai Stock: Low Valuation Masks Deeper Fundamental Concerns
  • Coherus BioSciences: A High-Stakes Pivot to Oncology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com